Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
BSE Buyback Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  Next >>
   
Security Code : 524604    Company : KAMRON LABORATORIES LTD.
08 Jul 2018
Shareholding for the Period Ended June 30, 2018Company Update 
  Exchange Disseminated Time     08/07/2018 08:33:51
Kamron Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here
 
06 Jul 2018
  Statement Of Investor Complaints For The Quarter Ended June 2018Company Update Download XBRL
  Exchange Received Time  06/07/2018 16:12:25         Exchange Disseminated Time   06/07/2018 16:12:29              Time Taken   00:00:04
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0211
Name of the Signatory :- Kamlesh Laskari
Designation :- Director
19 Jun 2018
Results-Financial Results For March 31, 2018ResultDownload PDFDownload XBRL
  Exchange Received Time  19/06/2018 16:12:56         Exchange Disseminated Time   19/06/2018 16:13:02              Time Taken   00:00:06
Kamron Laboratories Limited has informed and submitted to BSE:

1. Statement of Audited Financial Results for the year ended on 31st March, 2018.

2. Auditors' Report on the Audited Financial Results.

3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2018.
 
Board Meeting-Outcome of Board MeetingResultDownload PDFDownload XBRL
  Exchange Received Time  19/06/2018 16:05:15         Exchange Disseminated Time   19/06/2018 16:05:22              Time Taken   00:00:07
Board of Directors of Kamron Laboratories Limited in their meeting held on 29th May, 2018, have approved the Audited Financial Results for the financial year 2017-18 ended on 31st March, 2018.
 
07 May 2018
Board Meeting-Closure of Trading WindowInsider Trading / SASTDownload PDFDownload XBRL
  Exchange Received Time  07/05/2018 13:15:51         Exchange Disseminated Time   07/05/2018 13:15:56              Time Taken   00:00:05
Please note that pursuant to Code of Prevention for Insider Trading of the Company and applicable SEBI Regulations, the Company has informed all the designated employees and Directors that trading window for dealing in securities of the Company will be closed from 7th May, 2018 to 31st May, 2018 (both days inclusive).
 
Board Meeting-Board Meeting On May 29, 2018Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  07/05/2018 13:14:03         Exchange Disseminated Time   07/05/2018 13:14:11              Time Taken   00:00:08
The Meeting of the Board of Directors of Kamron Laboratories Limited to consider and approve the Standalone Audited Financial Results of the Company for the financial year 2017-18 ended on 31st March, 2018 is scheduled to be held on 29th May, 2018.
 
21 Apr 2018
Shareholding for the Period Ended March 31, 2018Company Update 
  Exchange Disseminated Time     21/04/2018 17:37:22
Kamron Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
 
19 Apr 2018
Compliances - PCS Certificate In Terms Of Reg. 40(9) Of SEBI (LODR) Regulations 2015 For Half Year Ended On 31St March, 2018Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  19/04/2018 15:10:36         Exchange Disseminated Time   19/04/2018 15:10:45              Time Taken   00:00:09
Kamron Laboratories Limited has submitted to BSE the Certificate by Practicing Company Secretary for Transfer / Transmission / Transposition for the half year ended on March 31, 2018.
 
07 Apr 2018
Compliances-Compliance Certificate For The Half Year Ended March, 2018Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  07/04/2018 18:10:46         Exchange Disseminated Time   07/04/2018 18:10:51              Time Taken   00:00:05
Kamron Laboratories Limited has submitted to BSE, Compliance Certificate under Reg. 7(3) for the half year ended on 31st March, 2018
 
06 Apr 2018
  Statement Of Investor Complaints For The Quarter Ended March 2018Company Update Download XBRL
  Exchange Received Time  06/04/2018 13:00:09         Exchange Disseminated Time   06/04/2018 13:00:16              Time Taken   00:00:07
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Kamlesh J. Laskari
Designation :- Director
15 Feb 2018
Corrigendum To Unaudited Financial Results For The Quarter Ended On Dec 31, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  15/02/2018 12:06:07         Exchange Disseminated Time   15/02/2018 12:06:11              Time Taken   00:00:04
Kamron Laboratories Limited has submitted BSE copy of Corrigendum to Unaudited Financial Results for the Quarter ended on Dec 31, 2017
 
14 Feb 2018
Results-Financial Results For Dec 31, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  14/02/2018 18:58:57         Exchange Disseminated Time   14/02/2018 18:59:03              Time Taken   00:00:06
Please note that the Board of Directors in their meeting held today i.e. 14th February, 2018 have taken on record the Unaudited Financial Results for the quarter ended on 31st December, 2017.

Please note that the company has adopted IND-AS for the first time from this financial year (2017-18).

We are enclosing herewith copy of the said Unaudited Financial Results.

This is as per Regulation - 33 of the SEBI (LODR) Regulations, 2015.
 
Board Meeting-Outcome of Board MeetingBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  14/02/2018 18:55:26         Exchange Disseminated Time   14/02/2018 18:55:32              Time Taken   00:00:06
Please note that the Board of Directors in their meeting held today i.e. 14th February, 2018 have taken on record the Unaudited Financial Results for the quarter ended on 31st December, 2017.

Please note that the company has adopted IND-AS for the first time from this financial year (2017-18).

We are enclosing herewith copy of the said Unaudited Financial Results.

This is as per Regulation - 33 of the SEBI (LODR) Regulations, 2015.
 
01 Feb 2018
Closure of Trading WindowInsider Trading / SASTDownload PDFDownload XBRL
  Exchange Received Time  01/02/2018 12:12:28         Exchange Disseminated Time   01/02/2018 12:12:37              Time Taken   00:00:09
Pursuant to Code of Prevention for Insider Trading of the Company and applicable SEBI Regulations, the Company has informed all the designated employees and Directors that trading window for dealing in securities of the Company will be closed from 1st February, 2018 to 16th February, 2018 (both days inclusive).
 
  Board Meeting On Feb 14, 2018Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  01/02/2018 12:11:08         Exchange Disseminated Time   01/02/2018 12:11:16              Time Taken   00:00:08
Kamron Laboratories Limited informs you that the next Meeting of the Board of Directors of the Company to consider and take on record the Unaudited Financial Results for the quarter ended on 31st December, 2017 is scheduled to be held on 14th February, 2018.

Please note that the Company has adopted IND-AS for the first time from this financial year (2017-18). ....
12 Jan 2018
Shareholding for the Period Ended December 31, 2017Company Update 
  Exchange Disseminated Time     12/01/2018 11:01:23
Kamron Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here
 
03 Jan 2018
Statement Of Investor Complaints For The Quarter Ended December, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  03/01/2018 14:33:56         Exchange Disseminated Time   03/01/2018 14:33:59              Time Taken   00:00:03
 
 
14 Dec 2017
Financial Results For Sep 30, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  14/12/2017 13:09:53         Exchange Disseminated Time   14/12/2017 13:10:00              Time Taken   00:00:07
Please note that the Board of Directors in their meeting held today i.e. 14th December, 2017 have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2017.

Please note that the company has adopted IND-AS for the first time from this financial year (2017-18).

This is as per Regulation - 33 of the SEBI (LODR) Regulations, 2015.
 
Outcome of Board MeetingResultDownload PDFDownload XBRL
  Exchange Received Time  14/12/2017 13:06:54         Exchange Disseminated Time   14/12/2017 13:07:00              Time Taken   00:00:06
Please note that the Board of Directors in their meeting held today i.e. 14th December, 2017 have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2017.

Please note that the company has adopted IND-AS for the first time from this financial year (2017-18).

This is as per Regulation - 33 of the SEBI (LODR) Regulations, 2015.
 
05 Dec 2017
Closure of Trading WindowInsider Trading / SASTDownload PDFDownload XBRL
  Exchange Received Time  05/12/2017 11:49:08         Exchange Disseminated Time   05/12/2017 11:49:13              Time Taken   00:00:05
Pursuant to Code of Prevention for Insider Trading of the Company and applicable SEBI Regulations, the Company has informed all the designated employees and Directors that trading window for dealing in securities of the Company will be closed from 5th December, 2017 to 16th December, 2017 (both days inclusive).
 

Disclaimer Next >>